variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
PPARG-P12A,PPARG,,Moderate,Uncertain,Not Reviewed,0.089,Other,Unknown,Heterozygous,16783862;17213274;17463248,rs1801282,3,chr3,12393125,G,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
AMPD1-Q12X,AMPD1,"Causes Adenosine Deaminase Deficiency in a recessive manner. Most of the time individuals do not report symptoms, but when symptoms do exist they to be post-exercise symptoms of muscle weakness, muscle pain, and getting tired more quickly.",Low,Likely,Pathogenic,0.093,"Metabolism;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,1631143,rs17602729,4,chr1,115236057,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
SCNN1G-E197K,SCNN1G,"May cause slight increased risk of rare, CFTR-like disease.",Low,Uncertain,Pathogenic,0.0064,Other,Dominant,Heterozygous,18507830;19462466,rs5738,1,chr16,23200963,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
TLR5-R392X,TLR5,"This variant is believed to impair the ability to generate an immune response to the flagella of the bacteria. It is weakly associated with an increased incidence of Legionnaires' Disease, p = 0.085, increased lifetime risk of disease ~0.88% (about twice average). The variant is also weakly associated with a reduced incidence of systemic lupus erythematosus, p = 0.165.",Low,Uncertain,Pathogenic,0.044,Immune system,Complex/Other,Heterozygous,14623910;16027372;17516623;18230059,rs5744168,1,chr1,223285200,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
POLG-Q1236H,POLG,"Generally a nonpathogenic polymorphism, but may have a modifier effect that increases severity when combined in cis with other pathogenic variants.",Low,Uncertain,Pathogenic,0.058,Other,Complex/Other,Heterozygous,15917273;16595552,rs3087374,0,chr15,89859994,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Heterozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
CPN1-G178D,CPN1,"This rare variant (around 1% allele frequency) is hypothesized to cause carboxypeptidase N deficiency in a recessive manner, especially if combined with a more severe variant. However the findings lack statistical sigificance: only a single case study of an affected individual links this variant to causing the disease. There arenâ€™t any follow-up in vitro studies testing whether this variant affects protein function.",Low,Uncertain,Pathogenic,0.036,Metabolism,Recessive,Heterozygous,12560874,rs61751507,5,chr10,101829514,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
DPYD-M166V,DPYD,Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ,High,Likely,Pharmacogenetic,0.078,Other,Unknown,Homozygous,11895907;14635116;19104657,rs2297595,5,chr1,98165091,C,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Homozygous,,rs1544410,0,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Homozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Homozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
PKD1-A4059V,PKD1,Probably benign.,Low,Likely,Benign,0.057,Other,Unknown,Heterozygous,19686598,rs3209986,,chr16,2140554,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Homozygous,,rs12742169,,chr1,201052310,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
KEL-T193M,KEL,This variant is also known as Kell or K1 or K (capitalized) in the Kell antigen system. K1-negative mothers (carrying no copies of this variant) carrying K1-positive fetuses (heterozygous or homozygous) are at risk for hemolytic disease of the newborn. About 9% of caucasians carry one or two copies of K1.,Low,Uncertain,Benign,0.032,Blood,Dominant,Heterozygous,7849312,rs8176058,,chr7,142655008,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
AMPD1-P48L,AMPD1,"Probably benign, ancestral to15173240 pathogenic Q12X mutation.",Low,Uncertain,Benign,0.094,Other,Unknown,Heterozygous,15173240,rs61752479,,chr1,115231254,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
DYNC2H1-Q304L,DYNC2H1,Presumed benign.,Low,Uncertain,Benign,0.048,Other,Unknown,Heterozygous,,rs12146610,,chr11,102988504,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
VWF-G2705R,VWF,"Probably benign, seems to be considered an uncommon polymorphism.",Low,Uncertain,Benign,0.046,Other,Unknown,Heterozygous,11439975,rs7962217,,chr12,6061559,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
ERCC6-R1230P,ERCC6,Probably benign.,Low,Uncertain,Benign,0.07,Other,Unknown,Heterozygous,,rs4253211,,chr10,50678317,G,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
GUCY2D-A52S,GUCY2D,"One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.",Low,Uncertain,Benign,0.21,Hearing and vision,Recessive,Heterozygous,8944027,rs61749665,,chr17,7906519,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
SPTA1-A970D,SPTA1,"This variant, also called alpha-IIa, has been seen frequently in individuals with recessive Hereditary spherocytosis. This appears to be the result of linkage to alpha-LEPRA (a C>T substitution at position -99 of intron 30); A970D is later reported as functionally neutral.",Low,Uncertain,Benign,0.037,Blood,Unknown,Heterozygous,8844207;9067503;15384986;16150946,rs35948326,,chr1,158624528,T,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Homozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.personalgenomes.org/genomes?display_genome_id=9f958a8d6ea43fdb6bfb8024921066aa82f80a1a&access_token=7f7e08a3f4910f1a9013d3d6069f7530
